News and Press Releases

Primera Selects Cenevo’s Labguru to Transition from Paper to Digitalised Workflow

London & Princeton, New Jersey – February 18, 2026 – Primera Analytical Solutions (Primera), an FDA-compliant analytical Contract Research Organization (CRO), has selected Cenevo’s Labguru electronic lab notebook (ELN) and inventory management platform to streamline its...

Category:
Posted: February 19, 2026

18/19 Bickels Yard 151-153 Bermondsey Street London SE1 3HA

Cold Chain Technologies boosts its commitment to Cell & Gene Therapies by partnering with Gobi Technologies

Cold Chain Technologies (CCT) has announced a strategic partnership with Gobi Technologies to give customers access to a greater range of temperature-controlled containers for Cell and Gene Therapies. The deal...

Category:
Posted: February 19, 2026

29 Everett Street, Holliston, MA 01746

Proveris Laboratories Launches Redesigned Website Focused on Analytical Clarity in OINDP Development

Hudson, MA, February 18, 2026 — Proveris Laboratories announced the launch of a redesigned website centered on its analytical and regulatory expertise in orally inhaled and nasal drug product (OINDP)...

Category:
Posted: February 19, 2026

2 Cabot Road, Hudson, MA

Emmes Coordinates Groundbreaking Stem-Cell Ophthalmology Trial

18 February 2026 -- Maryland, US -- Emmes, a full-service, global Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation – in collaboration with the UC Davis Eye...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 18, 2026

401 North Washington Street Suite 700 Rockville, MD 20850

Oncoinvent to Present Positive 24-month Follow-up Data from Phase 1 Ovarian Cancer Study of Radspherin at ESGO 2026

9 of 10 patients at the highest dose remained free from peritoneal recurrence at 24 months at the recommended dose 17 February 2026 -- Oslo, Norway -- Oncoinvent, a biotech...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 17, 2026

Gullhaugveien 7 0484 Oslo Norway

FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference

Presentation will highlight lead clinical candidate FMP374, a novel dual-acting NMDAR modulator advancing toward IND-enabling studies for TRD 17 February 2026 -- Heidelberg, Germany -- FundaMental Pharma GmbH, a preclinical-stage...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: February 17, 2026

Nikola-Tesla-Straße 1 D-69124 Heidelberg / Germany

Lytix Biopharma Publishes Comprehensive Review on the Transformative Potential of Oncolytic Peptides in Leading Cancer Journal (JITC)

17 February 2026 -- Oslo, Norway -- Lytix Biopharma AS, a clinical-stage immuno-oncology company, today announced the publication of a review article in the Journal of ImmunoTherapy of Cancer (JITC)....

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: February 17, 2026

Sandakerveien 138, 0484 Oslo, Norway

STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi

European Commission grants approval for Gotenfia, a golimumab biosimilar to Simponi that was developed by Bio-Thera and will be marketed by STADA Launch preparations are underway to bring the second...

Category: BioManufacturing, Drug Discovery, Manufacturing and Packing, Other, Pharmaceutical
Posted: February 13, 2026

Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant

11 February 2026 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 11, 2026

168 Third Avenue Waltham, MA 02451

Neogap secures SEK 87 million to advance clinical development of its personalised immunotherapy

11 February 2026 -- Solna, Sweden -- Neogap Therapeutics AB, a Swedish biotechnology company developing personalised immunotherapy for cancer treatment, has raised SEK 87 million in a financing round led...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 11, 2026

Stiftelsen Cancercentrum Karolinska (CCK) Visionsgatan 56 171 64 Solna, Sweden

Syngene Collaborates with Johns Hopkins University to Advance Early-Stage Drug Discovery

India/UK/US, 11 February, 2026: Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced a strategic collaboration with Johns Hopkins University, MD, U.S., to advance early‑stage drug...

Category:
Posted: February 11, 2026

Biocon Park, SEZ, Bommasandra Industrial Area – Phase-IV, Jigani Link Road, Bangalore, Karnataka – 560 099

Cold Chain Technologies boosts its commitment to Cell & Gene Therapies by partnering with Gobi Technologies

Cold Chain Technologies (CCT) has announced a strategic partnership with Gobi Technologies to give customers access to a greater range of temperature-controlled containers for Cell and Gene Therapies. The deal...

Category:
Posted: February 11, 2026

29 Everett Street, Holliston, MA 01746

Moderna Receives MHRA Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

The LP.8.1 vaccine is the first commercially licenced mRNA vaccine to be manufactured in the UK at the Moderna Innovation and Technology Centre in Oxfordshire The updated vaccines will be...

Category: Biotechnology, Drug Delivery, Drug Discovery, Other, Pharmaceutical
Posted: February 10, 2026

Global Headquarters 200 Technology Square Cambridge, MA 02139

Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies

Financing led by Investissement Québec with continued support from long-standing investors Plans include the acceleration of clinical development of breakthrough GPCR targeting treatments for patients. 10 February 2026 -- Montreal,...

Category: Drug Discovery, Other, Pharmaceutical
Posted: February 10, 2026

7171 Frederick Banting Montreal, QC H4S 1Z9 Canada

SPT Labtech and BellBrook Labs Introduce High-Throughput Screening Platform for Cancer Research

Automated workflow to be highlighted at SLAS 2026, 7-11 February, Boston Collaboration combines precision liquid handling technology with Transcreener ADP2 fluorescence polarization assay for screening of VPS4B ATPase inhibitors. 9...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 9, 2026

SPT Labtech Ltd. Melbourn Science Park Melbourn Hertfordshire SG8 6HB United Kingdom